Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adults.

Autor: Hopkins, Robert J.1 HopkinsR@ebsi.com, Howard, Cris1, Hunter-Stitt, Ericka1, Kaptur, Paulina E.2, Pleune, Brett3 PleuneB@ebsi.com, Muse, Derek4, Sheldon, Eric5, Davis, Matthew6, Strout, Cynthia7, Vert-Wong, Katya8
Zdroj: Vaccine. Apr2014, Vol. 32 Issue 19, p2217-2224. 8p.
Databáze: Academic Search Ultimate
Externí odkaz: